Repaglinide (1mg), Voglibose (0.3mg) .

Repaglinide (1mg), Voglibose (0.3mg)
RAPIGLINIDE VOG 1.0  
Repaglinide and voglibose are both medications used in the management of type 2 diabetes mellitus. They belong to different classes of antidiabetic drugs and work in different ways to help control blood sugar levels.
Repaglinide is an oral hypoglycemic agent classified as a meglitinide. Repaglinide is often prescribed to individuals with type 2 diabetes who cannot achieve adequate blood sugar control through diet and exercise alone.
Repaglinide works by stimulating the release of insulin from the pancreas, particularly after meals. Repaglinide helps lower blood glucose levels by enhancing insulin secretion and reducing hepatic glucose production.
Voglibose is an oral alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates in the intestines. Voglibose is used as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes.
By inhibiting the action of alpha-glucosidase enzymes in the small intestine, voglibose delays the breakdown of complex carbohydrates into simple sugars. This leads to a slower and more gradual rise in blood glucose levels after meals.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/rapiglinide-vog-1-0-134237